NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

ECRI Evaluates CADD-Solis v4 Wireless Ambulatory Infusion System

Smiths Medical CADD-Solis v4

Smiths Medical has announced the release of the ECRI evaluation report for CADD-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump. ECRI is an independent non-profit organization improving the safety, quality, and cost-effectiveness of care across all health care settings worldwide. The report highlights ECRI’s evaluation ratings, test results and purchasing recommendations for the CADD-Solis pump.

The CADD-Solis v4 system is a continuation of Smiths Medical’s commitment to advance patient care and help improve patient outcomes through leading-edge technology.

The CADD-Solis pump maintains the advantages of an ambulatory pump for patient mobility and provides a single system that effectively delivers IV PCA, epidural, peripheral nerve blocks and subcutaneous from pump to patient. For the hospital, the CADD-Solis system is designed to enhance patient safety through “smart programming” (use of medication safety software) and reduce the risk of tubing misconnections while providing a comprehensive and intuitive user experience for the health care provider.

“Smiths Medical is committed to patient safety and adoption of smart infusion pumps,” said Nathan Walker, director of ambulatory infusion at Smiths Medical. “The wireless bi-directional communication sets the foundation for integrating pain management data delivery directly into the patient records in the hospital’s Electronic Health Records (EHR auto-documentation), saving clinicians time charting and increasing documentation accuracy.”

For more information about the CADD-Solis PCA and epidural pump and to request a copy of the report visit https://www.smiths-medical.com/CADD-Solis-Infusion-System.

For more information, visit www.smiths-medical.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X